Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.
Latest SPAC News: SPACs may be a boon to CLO equity returns and SAB Biotherapeutics receives positive safety review
SPAC Acquisitions of Distressed Companies Help Drive CLO Returns
The increase of SPACs is yet another positive factor working in favor of the red-hot collateralized loan obligation market, which is very close to achieving an annual sales record, according to CLO equity investor Flat Rock Global.
That’s because having SPACs hunt for acquisition targets in the riskiest borrowers within CLO loan pools may mean credits that currently trade somewhat below par can trade back up to that price as a result of the SPAC merger process, Shiloh Bates, managing director at Flat Rock, said in a telephone interview with Bloomberg.
READSAB Biotherapeutics Announces SAB-185 Receives Positive DSMB Review and Advances to Phase 3 in NIH-Sponsored ACTIV-2 Trial for Treatment of COVID-19
SAB Biotherapeutics, a clinical-stage biopharmaceutical company with a novel immunotherapy platform that produces specifically targeted, fully-human polyclonal antibodies without the need for human donors, today announced that an independent Data Safety Monitoring Board (DSMB) has completed its prespecified interim analysis data review of the safety and efficacy of SAB-185 in the Phase 2 portion of the ACTIV-2 trial and has recommended advancement to Phase 3.
SAB-185 is a fully-human, specifically-targeted, broadly-neutralizing polyclonal antibody therapeutic candidate for the treatment of non-hospitalized patients with mild to moderate COVID-19.
On June 22, SAB announced a planned merger with Big Cypress Acquisition Corp. (NASDAQ: BCYP). The transaction is expected to close in the fourth quarter of 2021.
READ
Sizzle Acquisition Corp. II (NASDAQ: SZZLU) announced the pricing of its $200 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “SZZLU”, Wednesday, April 2, 2025. Sizzle II plans to search for a target in a range of industries and combine with an established business of scale poised...
In March 2025, SPAC activity remained largely in line with February, though notable shifts emerged across extensions, announced transactions, and completions. Extension activity remained steady, with a slight increase in the number of SPACs seeking additional time. However, later-stage extensions became more common, reflecting a maturing SPAC landscape. Announced transaction volume continued to be weak,...
Best SPAC I (NASDAQ:BSAAU) has filed for a $55 million SPAC with a search focus targeting consumer goods companies from its base in Hong Kong. Maxim is taking just 1.0% fees up front and will not take a deferred fee. This upfront fee will also apply only to proceeds in the offering from investors brought...
At the SPAC of Dawn Two new SPACs priced their IPOs yesterday, showing that SPACs at least are not entirely spooked by the markets continued downturn. Futures continue to be beet red heading into the second day of the week, particularly for the SPAC-favorite exchange Nasdaq. SPACs have the potential to shine in this environment,...
An In-Depth Look at SPAC Activity Through the First Quarter 2025 Below is a summary of the Q1-2025 SPAC market. If you’d like a pdf copy, you can access the link HERE. While SPAC IPO issuance has continued to climb modestly in Q1, it’s doing so at a more sustainable and disciplined pace compared to...